Research view
Switch to patient viewMetastatic breast cancer: who works on it
Groups that published on this disease or run trials on it, from public registries and publications. Researchers appear by name only once their profile is published.
Find fellow researchers
One card per institution. Pick a target or a country to narrow the list.
- All targets
- HER2 193
- CDK4/6 49
- PIK3CA 24
- ESR1 11
- PD-L1 10
- BRCA1 2
- PI3K 13
- PARP 7
- BRCA2 2
- AKT 4
- PD-1 10
- STAT3 0
- PTEN 2
- TP53 0
- mTOR 5
- TROP2 4
- STING 0
- VEGF 4
- YAP 0
- PALB2 3
- MMP-9 0
- AR 0
- CXCR4 1
- EGFR 3
- HER3 4
- AMPK 0
- HDAC 1
- JAK 1
- CTNNB1 0
- FGFR 1
- PSMA 0
- ATM 0
- CD40 1
- EZH2 0
- FAK 0
- HIF-1 0
- MUC1 3
- PPAR 0
- BCL-2 1
- CD47 1
- COX-2 0
- ERK 0
- HSP90 0
- IGF1R 0
- IL-6 0
- MDM2 2
- MET 0
- MYC 0
- TNF 0
- B7-H3 1
- CCR5 0
- CSF1R 0
- CTLA-4 1
- JNK 0
- LAG-3 0
- MAPK 0
- NF1 0
- NRF2 0
- RANKL 0
- TIGIT 0
Running research funding
Funded research projects that name this disease in their title, terms or summary and have not ended yet: who is funded, where, how much and until when. Organisations only; the funder's page has the details.
U.S. Department of Veterans Affairs · IK1
NIH NIDA · UG3
Development of a Novel Treatment for Benzodiazepine Addiction
NIH NINR · F31
NIH NIAID · R56
Functional dissection of a novel E2 complex critical for the HPV16 life cycle
NIH NCI · R15
European Commission (Horizon Europe) · HORIZON-TMA-MSCA-PF-EF
European Commission (Horizon Europe) · HORIZON-TMA-MSCA-SE
European Commission (Horizon Europe) · HORIZON-TMA-MSCA-PF-EF
Mapping antigenic niches of tumor-infiltrating B cells in triple-negative breast cancer (MAP-BC)
European Commission (Horizon Europe) · HORIZON-ERC
Re-wiring tumor immune-evasive plasticity with mRNA therapy (PLASTWIRE)
European Commission (Horizon Europe) · HORIZON-ERC-POC
Multispecific theranostic nano-engager platform (Nano-BITE)
The disease is named only in the funder's project summary, not in the title.
10 of 2,354 running projects, newest first. Listed amounts together: US$1.3bn + €289.4m.
Sources: NIH RePORTER (U.S. National Institutes of Health, public domain) and CORDIS (European Commission, CC BY 4.0). Changes: filtered by disease, organisations matched to ROR.
Trials that share participant data
Trials whose registry record says individual participant data (IPD) will be shared.
No trial in this view states that it shares participant data.
Search by method
Find publications on this disease by a MeSH method term, for example a sequencing or imaging method.
- Single-Cell Analysis 21
- Organoids 7
- CRISPR-Cas Systems 4
- Gene Expression Profiling 63
- Sequence Analysis, RNA 1
- Whole Genome Sequencing 3
- Exome Sequencing 5
- Proteomics 16
- Metabolomics 3
- Mass Spectrometry 1
- Flow Cytometry 9
- Immunohistochemistry 70
- Liquid Biopsy 19
- Circulating Tumor DNA 46
- Xenograft Model Antitumor Assays 109
- Positron-Emission Tomography 13
- Magnetic Resonance Imaging 64
- Machine Learning 30
- Deep Learning 23
- Cohort Studies 57
- Genome-Wide Association Study 1
Paste an abstract
See which targets of this disease your abstract mentions, and go to the people working on them.
Matched in your browser only. The text is not sent, saved or logged.
Sources: ClinicalTrials.gov, EU CTR, OpenAlex, PubMed, NIH RePORTER, CORDIS. Machine-matched links are labelled.